Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
Johns Hopkins University
Johns Hopkins University
Harvard Medical School (HMS and HSDM)
Xiangya Hospital of Central South University
Norwegian University of Science and Technology
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Children's Hospitals and Clinics of Minnesota
Karolinska University Hospital
Second Affiliated Hospital of Nanchang University
Tampere University Hospital